---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-031605"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2024-03-07T23:59:59+00:00"
generated_at: "2026-06-05T01:49:21.431664+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Orchestra BioMed files corporate presentation; no material updates provided

## Summary
- Filed an investor slide presentation used at Q1 2024 conferences.
- Presentation contains only standard forward-looking statement disclaimers.
- No earnings, guidance, or material business events disclosed in the filing.

## SEC filing metadata
- accession: 0001104659-24-031605
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2024-03-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000110465924031605/0001104659-24-031605-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000110465924031605/tm248150d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-031605
- JSON: https://secwatch.observer/filing/0001104659-24-031605.json
- Plain text: https://secwatch.observer/filing/0001104659-24-031605.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.